Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xizhong Cui

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Current Infectious Disease Reports|August 31, 2013
The Surviving Sepsis Campaign's Revised Sepsis BundlesAmisha V Barochia, Xizhong Cui, Peter Q Eichacker
American Journal of Respiratory and Critical Care Medicine|November 11, 2006
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapyKevin Sherer, Yan Li, Xizhong Cui, et al.
Critical Care Medicine|April 10, 2002
Inhaled nitric oxide: is systemic host defense at risk?Xizhong Cui, Zenaide M N Quezado, Peter Q Eichacker
Expert Opinion on Biological Therapy|June 9, 2007
New insights into the pathogenesis and treatment of anthrax toxin-induced shockYan Li, Kevin Sherer, Xizhong Cui, et al.
Critical Care Medicine|December 22, 2009
Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsisAmisha V Barochia, Xizhong Cui, Charles Natanson, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.
Expert Opinion on Investigational Drugs|April 30, 2015
An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsisLernik Ohanjanian, Kenneth E Remy, Yan Li, et al.
BMC Medicine|October 11, 2013
B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin componentsKenneth E Remy, Ping Qiu, Yan Li, et al.
Toxins|December 7, 2017
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema ToxinsDante A Suffredini, Xizhong Cui, Wanying Xu, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2011
Anthrax infectionDaniel A Sweeney, Caitlin W Hicks, Xizhong Cui, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Current Infectious Disease Reports|August 31, 2013
The Surviving Sepsis Campaign's Revised Sepsis BundlesAmisha V Barochia, Xizhong Cui, Peter Q Eichacker
American Journal of Respiratory and Critical Care Medicine|November 11, 2006
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapyKevin Sherer, Yan Li, Xizhong Cui, et al.
Critical Care Medicine|April 10, 2002
Inhaled nitric oxide: is systemic host defense at risk?Xizhong Cui, Zenaide M N Quezado, Peter Q Eichacker
Expert Opinion on Biological Therapy|June 9, 2007
New insights into the pathogenesis and treatment of anthrax toxin-induced shockYan Li, Kevin Sherer, Xizhong Cui, et al.
Critical Care Medicine|December 22, 2009
Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsisAmisha V Barochia, Xizhong Cui, Charles Natanson, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.
Expert Opinion on Investigational Drugs|April 30, 2015
An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsisLernik Ohanjanian, Kenneth E Remy, Yan Li, et al.
BMC Medicine|October 11, 2013
B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin componentsKenneth E Remy, Ping Qiu, Yan Li, et al.
Toxins|December 7, 2017
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema ToxinsDante A Suffredini, Xizhong Cui, Wanying Xu, et al.
American Journal of Respiratory and Critical Care Medicine|August 20, 2011
Anthrax infectionDaniel A Sweeney, Caitlin W Hicks, Xizhong Cui, et al.
Pageof 9